Document is current
Any future updates will be listed below
-
Authors
Humeau, Juliette
Sauvat, Allan
Cerrato, Giulia
Xie, Wei
Loos, Friedemann https://orcid.org/0000-0002-5976-5978
Iannantuoni, Francesca
Bezu, Lucillia
Lévesque, Sarah
Paillet, Juliette
Pol, Jonathan https://orcid.org/0000-0002-8355-7562
Leduc, Marion
Zitvogel, Laurence
de Thé, Hugues
Kepp, Oliver https://orcid.org/0000-0002-6081-9558
Kroemer, Guido https://orcid.org/0000-0002-9334-4405
-
Funding
Funding for this research was provided by:
Ligue contre le Cancer
Agence National de la Recherche
Association pour la recherche sur le cancer
Cancéropôle Ile‐de‐France
Chancellerie des universités de Paris
Fondation pour la Recherche Médicale
Elior
European Research Area Network on Cardiovascular Diseases
Gustave Roussy Odyssea
European Union Horizon 2020 Project Oncobiome
Fondation Carrefour
High‐end Foreign Expert Program in China (GDW20171100085)
High‐end Foreign Expert Program in China (GDW20181100051)
Institut National du Cancer
Inserm
Institut Universitaire de France
LeDucq Foundation
LabEx Immuno‐Oncology
RHU Torino Lumière
Seerave Foundation
SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination
SIRIC Cancer Research and Personalized Medicine
Foundation Philanthropia
China Scholarship Council
BMS
Regional Ministry for Education in Valencia (GRISOLIAP/2016/015)
Regional Ministry for Education in Valencia‐European Social Fund (BEFPI/2018/030)
Fondation pour la recherche médicale (FRM ‐ FDT201805005722)
- License Information
-
More Information
Article History
Received: 16 October 2019
Revised: 25 March 2020
Accepted: 30 March 2020
First Online: 23 April 2020
Conflict of interest
: G.K. and O.K. are cofounders of Samsara Therapeutics.
